Evidence map›Paper›PMID 33065265›Full record

ArticleMicrobes and infection

SARS-CoV-2 testing in low- and middle-income countries: availability and affordability in the private health sector.

Lena Faust, Alexandra J Zimmer, Mikashmi Kohli, Senjuti Saha, Jody Boffa, Marlon L Bayot, Ifeanyi Nsofor, Leonel Campos, Tivani Mashamba-Thompson, Rosa Herrera and 17 more

Abstract readLetter
In one paragraph

Article in Microbes and infection. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Biosafety and biosecurity challenges during the COVID-19 pandemic and beyond.Frontiers in bioengineering and biotechnology · 2023
    Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Lena FaustMcGill International TB Centre, Montreal, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.
Alexandra J ZimmerMcGill International TB Centre, Montreal, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.
Mikashmi KohliMcGill International TB Centre, Montreal, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.
Senjuti SahaChild Health Research Foundation, Dhaka, Bangladesh.
Jody BoffaDahdaleh Institute for Global Health, York University, Canada; Centre for Rural Health, University of KwaZulu-Natal, South Africa.
Marlon L BayotCoach MLB Consulting, Metro Manila, Philippines.
Ifeanyi NsoforEpiAFRIC, Abuja, Nigeria.
Leonel CamposHospital Sírio-Libanês, São Paulo, Brazil.
Tivani Mashamba-ThompsonDepartment of Public Health, Faculty of Health Sciences, University of Limpopo, South Africa.
Rosa HerreraInstituto de Servicios de Salud Pública del Estado de Baja California, Mexico.
Elom EmekaTB Laboratory Services Unit, NTBLCP, Federal Ministry of Health, Dept of Public Health, Federal Capital Territory, Abuja, Nigeria.
Suvesh ShresthaSave the Children, Kathmandu, Nepal.
Cesar Ugarte-GilInstituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru; School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru.
Achilles KatambaClinical Epidemiology & Biostatistics Unit, Department of Medicine School of Medicine, Makerere University College of Health Sciences, Uganda; Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.
Imran PambudiNational TB Program, Jakarta, Indonesia.
David BicharaScientific Department of Amaral Costa Laboratory, Belém, PA, Brazil.
Roger I CalderonSocios En Salud Sucursal Peru, Lima, Peru; Programa Acadêmico de Tuberculose, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Namatullah AhmadzadaNational TB Control Program, Kabul, Afghanistan.
Muhammad Aamir SafdarNational TB Control Program, Pakistan.
Chaitali NikamThyrocare Technologies Limited, India.
Carolina Dos Santos LázariInfectious Disease Medical Department, Grupo Fleury, Brazil; Molecular Biology Section, Central Laboratory Division, University of São Paulo Clinical Hospital, Brazil.
Hamidah HussainInteractive Research and Development (IRD) Global, Pakistan.
Myint Myint WinPATH, Myanmar.
Kyaw Zin ThanPATH, Myanmar.
Anthony AhumibeNigeria Centre for Disease Control, Nigeria.
Brenda WaningStop TB Partnership, Geneva, Switzerland.
Madhukar PaiMcGill International TB Centre, Montreal, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada. Electronic address: madhukar.pai@mcgill.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Costs and Cost AnalysisCOVID-19COVID-19 TestingDeveloping CountriesHumansPandemicsPrivate SectorSARS-CoV-2

Identifiers

PMID33065265
PMCPMC7553871

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.